The latest closing stock price for Alnylam Pharmaceuticals as of November 20, 2024 is 248.79.
An investor who bought $1,000 worth of Alnylam Pharmaceuticals stock at the IPO in 2004 would have $34,541 today, roughly 35 times their original investment - a 19.55% compound annual growth rate over 20 years.
The all-time high Alnylam Pharmaceuticals stock closing price was 300.55 on October 16, 2024.
The Alnylam Pharmaceuticals 52-week high stock price is 304.39, which is 22.3% above the current share price.
The Alnylam Pharmaceuticals 52-week low stock price is 141.97, which is 42.9% below the current share price.
The average Alnylam Pharmaceuticals stock price for the last 52 weeks is 205.56.
An investor who bought $1,000 worth of Alnylam Pharmaceuticals stock at the IPO in 2004 would have $34,541 today, roughly 35 times their original investment - a 19.55% compound annual growth rate over 20 years.
The all-time high Alnylam Pharmaceuticals stock closing price was 300.55 on October 16, 2024.
The Alnylam Pharmaceuticals 52-week high stock price is 304.39, which is 22.3% above the current share price.
The Alnylam Pharmaceuticals 52-week low stock price is 141.97, which is 42.9% below the current share price.
The average Alnylam Pharmaceuticals stock price for the last 52 weeks is 205.56.